Blog
Research
The Therapeutic Potential of Psilocybin
The medical use of psilocybin, the main psychoactive component of psilocybin-producing (“magic”) mushrooms, has been explored in a litany of ...
Education
How Psychedelics Can Treat Eating Disorders
Nearly 30 million Americans suffer from an eating disorder, resulting in 10,200 deaths annually. Perhaps more than other mental illnesses, eating ...
Business
Why Isn’t Big Pharma Jumping Into Psychedelics?
Big Pharma is at a crossroads. The industry’s business model relies largely on returning customers for its revenue, especially when ...
Education
How Psychedelics Can Help Palliative and End-of-Life Care
Over 40 million people require palliative or end-of-life care each year. Terminally ill people often experience existential distress, which includes ...
Business
The Future of MDMA Therapy: Promising Next Steps
The past decade has seen numerous clinical trials focused on the medicinal and psychological benefits of psychedelics. The results couldn’t ...
Education
the Difference Between Psilocybin and LSD
Not too long ago, talking in public about the differences between psilocybin and LSD would probably draw some odd looks ...
Business
The Three Biggest Challenges Facing the Psychedelics Sphere
Psychedelics have come a long way in the last 20 years. For proof of that, simply look to the growing ...
Education
Ayahuasca, DMT, and LSD – What’s the Difference?
Psychedelic research has entered the third act of its own fairytale. Scientific interest in compounds like ayahuasca, DMT, and LSD ...
People
David Champion: Digital Solutions in Psychedelics
David Champion, CEO of Maya Health, has been a front-line player in this space from the level of grassroots organizer on ...
People
DoubleBlind Co-Founder Madison Margolin On the Future of Psychedelics
We had the pleasure of recently interviewing Madison Margolin, co-founder of DoubleBlind Magazine. Our discussion ranged from the magazine’s aesthetic ...
